| 6281- | DL, | Applications of Limonene in Neoplasms and Non-Neoplastic Diseases |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Diabetic, | NA |
| 6280- | DL, | Biochemical significance of limonene and its metabolites: future prospects for designing and developing highly potent anticancer drugs |
| - | Review, | Var, | NA |
| 6279- | DL, | Human breast tissue disposition and bioactivity of limonene in women with early stage breast cancer |
| - | Trial, | BC, | NA |
| 6276- | DL, | Tam, | Combination of tamoxifen and D-limonene enhances therapeutic efficacy in breast cancer cells |
| - | in-vitro, | BC, | MCF7 |
| 6283- | DL, | D-limonene inhibits peritoneal adhesion formation in rats via anti-inflammatory, anti-angiogenic, and antioxidative effects |
| - | in-vivo, | Nor, | NA |
| 6728- | DMSO, | Molecular basis for dimethylsulfoxide (DMSO) action on lipid membranes |
| - | in-vitro, | Nor, | NA |
| 6727- | DMSO, | The permeability enhancing mechanism of DMSO in ceramide bilayers simulated by molecular dynamics |
| - | in-vitro, | Var, | NA |
| 6726- | DMSO, | DMSO induces apoptosis in SV40-transformed human keratinocytes, but not in normal keratinocytes |
| - | in-vitro, | Var, | NA |
| 6725- | DMSO, | DMSO induces dehydration near lipid membrane surfaces |
| - | Study, | Nor, | NA |
| 6724- | DMSO, | Ion transport through dimethyl sulfoxide (DMSO) induced transient water pores in cell membranes |
| - | in-vitro, | Nor, | NA |
| 6723- | DMSO, | Modulating the structure and properties of cell membranes: the molecular mechanism of action of dimethyl sulfoxide |
| - | Review, | Nor, | NA |
| 5386- | docx, | AsP, | Co-delivery of docetaxel and palmitoyl ascorbate by liposome for enhanced synergistic antitumor efficacy |
| - | vitro+vivo, | Liver, | HepG2 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Pca, | PC3 |
| 6328- | DRE, | Hydroalcoholic extract of Taraxacum officinale induces apoptosis and autophagy in 4T1 breast cancer cells |
| - | in-vitro, | BC, | 4T1 |
| 6329- | DRE, | VitA,RetA, | Combined dandelion extract and all-trans retinoic acid induces cytotoxicity in human breast cancer cells |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
| 6342- | DRE, | Mechanistic Study on the Inhibitory Effect of Dandelion Extract on Breast Cancer Cell Proliferation and Its Induction of Apoptosis |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Nor, | MCF10 |
| 6343- | DRE, | Dandelion root extract affects ESCC progression via regulating multiple signal pathways |
| - | vitro+vivo, | ESCC, | NA |
| 6344- | DRE, | Dandelion: Purported Benefits, Side Effects & More |
| - | Review, | Var, | NA |
| 6345- | DRE, | Human clinical trials on for cancer killing dandelion extract |
| - | Review, | AML, | NA |
| 6346- | DRE, | Unusual Response of Acute Monocytic Leukemia to Dandelion Root Extract |
| - | Case Report, | AML, | NA |
| 6347- | DRE, | Protective Effects of Taraxacum officinale L. (Dandelion) Root Extract in Experimental Acute on Chronic Liver Failure |
| - | in-vivo, | LiverDam, | NA |
| 6348- | DRE, | New prospects in oncotherapy: bioactive compounds from Taraxacum officinale |
| - | Review, | Var, | NA |
| 6349- | DRE, | Dandelion root extract protects NCM460 colonic cells and relieves experimental mouse colitis |
| - | vitro+vivo, | Nor, | NCM460 |
| 6350- | DRE, | Tracking Evidences of Dandelion for the Treatment of Cancer: From Chemical Composition, Bioactivity, Signaling Pathways in Cancer Cells to Perspective Study |
| - | Review, | Var, | NA |
| 6326- | DRE, | MT/VAE, | Taraxacum officinale extract shows antitumor effects on pediatric cancer cells and enhance mistletoe therapy |
| - | in-vitro, | neuroblastoma, | SH-SY5Y |
| 6317- | DRE, | The efficacy of dandelion root extract in inducing apoptosis in drug-resistant human melanoma cells |
| - | in-vitro, | Melanoma, | A375 |
| 6318- | DRE, | Dandelion root extract affects colorectal cancer proliferation and survival through the activation of multiple death signalling pathways |
| - | vitro+vivo, | CRC, | HCT116 | - | NA, | Nor, | NCM460 |
| 6319- | DRE, | Efficient induction of extrinsic cell death by dandelion root extract in human chronic myelomonocytic leukemia (CMML) cells |
| - | in-vitro, | AML, | MV411 | - | in-vitro, | AML, | HL-60 |
| 6320- | DRE, | Selective induction of apoptosis and autophagy through treatment with dandelion root extract in human pancreatic cancer cells |
| - | in-vitro, | PC, | Bxpc-3 | - | in-vitro, | PC, | PANC1 |
| 6321- | DRE, | Dandelion root extract suppressed gastric cancer cells proliferation and migration through targeting lncRNA-CCAT1 |
| - | in-vitro, | GC, | NA |
| 6322- | DRE, | LGE, | Dandelion Root and Lemongrass Extracts Induce Apoptosis, Enhance Chemotherapeutic Efficacy, and Reduce Tumour Xenograft Growth In Vivo in Prostate Cancer |
| - | vitro+vivo, | Pca, | DU145 |
| 6327- | DRE, | Effect of Methanolic Extract of Dandelion Roots on Cancer Cell Lines and AMP-Activated Protein Kinase Pathway |
| - | in-vitro, | Liver, | HepG2 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Nor, | Hs27 |
| 6357- | DRE, | New Perspectives on the Effect of Dandelion, Its Food Products and Other Preparations on the Cardiovascular System and Its Diseases |
| - | Review, | Nor, | NA |
| 6353- | DRE, | Cisplatin, | Insights Into Protective Mechanisms of Dandelion Leaf Extract Against Cisplatin-Induced Nephrotoxicity in Rats: Role of Inhibitory Effect on Inflammatory and Apoptotic Pathways |
| - | in-vivo, | Nor, | NA |
| 6354- | DRE, | Taraxacum officinale L. in leukemia and lymphoma: current knowledge and prospects for horticulture |
| - | Review, | AML, | NA |
| 6351- | DRE, | Rad, | Differential effect of Taraxacum officinale L. (dandelion) root extract on hepatic and testicular tissues of rats exposed to ionizing radiation |
| - | in-vivo, | Nor, | NA |
| 6352- | DRE, | Investigation of the Anti-Lung Cancer Mechanisms of Taraxacum officinale Based on Network Pharmacology and Multidimensional Experimental Validation |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Nor, | L929 |
| 6365- | DRE, | AN OVERVIEW OF THERAPEUTIC POTENTIALS OF TARAXACUM OFFICINALE (DANDELION): A TRADITIONALLY VALUABLE HERB WITH A REACH HISTORICAL BACKGROUND |
| - | Review, | Var, | NA |
| 6358- | DRE, | Dandelion root extracts and taraxasterol inhibit LPS‑induced colorectal cancer cell viability by blocking TLR4‑NFκB‑driven ACE2 and TMPRSS2 pathways |
| - | in-vitro, | CRC, | NA |
| 6359- | DRE, | Natural Health Products (NHP’s) and Natural Compounds as Therapeutic Agents for the Treatment of Cancer; Mechanisms of Anti-Cancer Activity of Natural Compounds and Overall Trends |
| - | Review, | Var, | NA |
| 6360- | DRE, | Dandelion Seed Extract Affects Tumor Progression and Enhances the Sensitivity of Cisplatin in Esophageal Squamous Cell Carcinoma |
| - | in-vitro, | ESCC, | KYSE450 | - | in-vitro, | ESCC, | Eca109 |
| 6367- | DRE, | Antioxidant and antimicrobial activities of Dandelion root extract (Taraxacum officinale) and its cytotoxic effect on MDA-MB-231 breast cancer cells |
| - | in-vitro, | BC, | MDA-MB-231 |
| 6361- | DRE, | Taraxacum officinale Seed Extract Inhibits HeLa Cell Migration at Sub-cytotoxic Concentrations |
| - | in-vitro, | Cerv, | HeLa |
| 6362- | DRE, | Taraxacum spp. in vitro and in vivo anticancer activity – A review |
| - | Review, | Var, | NA |
| 6363- | DRE, | Therapeutic Potential of Dandelion (Taraxacum officinale) Root Extract in Colon Cancer: A Comprehensive Review |
| - | in-vitro, | CRC, | NA |
| 6364- | DRE, | Dandelion Root Extract Sensitizes Leukemia Cells to VP-16 Induced Cell Death |
| - | in-vitro, | CLL, | NA |
| 6366- | DRE, | A comprehensive review of the benefits of Taraxacum officinale on human health |
| - | Review, | Var, | NA |
| 6738- | DSF, | Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4 |
| - | Review, | Var, | NA |
| 6743- | DSF, | Disulfiram/Copper Activates ER Stress to Promote Immunogenic Cell Death of Oral Squamous Cell Carcinoma |
| - | in-vitro, | OS, | NA |
| 6742- | DSF, | Localized Sustained Release of Copper Enhances Anti-Tumor Effects of Disulfiram in Head and Neck Cancer |
| - | in-vitro, | HNSCC, | NA |
| 6741- | DSF, | Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET |
| - | vitro+vivo, | Lung, | A549 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid